Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Molecular Partners Ag (MOLN) Assets: 2021-2025

Historic Assets for Molecular Partners Ag (MOLN) over the last 4 years, with Sep 2025 value amounting to $140,196.

  • Molecular Partners Ag's Assets fell 21.23% to $140,196 in Q3 2025 from the same period last year, while for Sep 2025 it was $140,196, marking a year-over-year decrease of 21.23%. This contributed to the annual value of $180,199 for FY2024, which is 18.41% down from last year.
  • As of Q3 2025, Molecular Partners Ag's Assets stood at $140,196, which was down 6.59% from $150,083 recorded in Q2 2025.
  • Molecular Partners Ag's Assets' 5-year high stood at $337,665 during Q1 2022, with a 5-year trough of $140,196 in Q3 2025.
  • For the 3-year period, Molecular Partners Ag's Assets averaged around $199,888, with its median value being $188,667 (2024).
  • In the last 5 years, Molecular Partners Ag's Assets soared by 45.38% in 2022 and then decreased by 27.92% in 2024.
  • Quarterly analysis of 5 years shows Molecular Partners Ag's Assets stood at $187,259 in 2021, then spiked by 45.38% to $272,230 in 2022, then declined by 17.86% to $223,613 in 2023, then declined by 19.07% to $180,963 in 2024, then dropped by 21.23% to $140,196 in 2025.
  • Its Assets stands at $140,196 for Q3 2025, versus $150,083 for Q2 2025 and $156,935 for Q1 2025.